These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2009533)
21. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474 [TBL] [Abstract][Full Text] [Related]
22. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. Baker AH; Zaltsman AB; George SJ; Newby AC J Clin Invest; 1998 Mar; 101(6):1478-87. PubMed ID: 9502791 [TBL] [Abstract][Full Text] [Related]
23. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Dittmann KH; Lottspeich F; Ries C; Petrides PE Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672 [TBL] [Abstract][Full Text] [Related]
24. In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor. Cresson DH; Beckman WC; Tidwell RR; Geratz JD; Siegal GP Am J Pathol; 1986 Apr; 123(1):46-56. PubMed ID: 3008561 [TBL] [Abstract][Full Text] [Related]
25. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512 [TBL] [Abstract][Full Text] [Related]
26. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line. Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514 [TBL] [Abstract][Full Text] [Related]
27. [Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis]. Okada A Gan To Kagaku Ryoho; 1999 Dec; 26(14):2247-52. PubMed ID: 10635313 [TBL] [Abstract][Full Text] [Related]
28. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805 [TBL] [Abstract][Full Text] [Related]
29. Invasion of an artificial blood vessel wall by human fibrosarcoma cells. Jones PA; Neustein HB; Gonzales F; Bogenmann E Cancer Res; 1981 Nov; 41(11 Pt 1):4613-20. PubMed ID: 7306979 [TBL] [Abstract][Full Text] [Related]
30. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Terada T; Okada Y; Nakanuma Y Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149 [TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427 [TBL] [Abstract][Full Text] [Related]
32. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. Ramer R; Hinz B J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069 [TBL] [Abstract][Full Text] [Related]
34. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336 [TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160 [TBL] [Abstract][Full Text] [Related]
36. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases. Sharma RK In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804 [TBL] [Abstract][Full Text] [Related]
37. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
38. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Welgus HG; Senior RM; Parks WC; Kahn AJ; Ley TJ; Shapiro SD; Campbell EJ Matrix Suppl; 1992; 1():363-7. PubMed ID: 1480061 [TBL] [Abstract][Full Text] [Related]
39. Expression and function of matrix metalloproteinases in development. Werb Z; Alexander CM; Adler RR Matrix Suppl; 1992; 1():337-43. PubMed ID: 1480058 [TBL] [Abstract][Full Text] [Related]
40. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. Campbell EJ; Cury JD; Shapiro SD; Goldberg GI; Welgus HG J Immunol; 1991 Feb; 146(4):1286-93. PubMed ID: 1991967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]